Ahead of the G7 Leaders’ Summit in Kananaskis from 15 to 17 2025, the global pharmaceutical industry, represented by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Innovative Medicines Canada (IMC), are calling on G7 governments to place health and innovation at the top of their agenda.
Read moreAhead of the G7 Leaders’ Summit, IFPMA and Innovative Medicines Canada (IMC) reaffirm the innovative pharmaceutical industry’s commitment to partnering with G7 governments to improve patient outcomes, strengthen health systems, boost economic growth, and support national security.
Read more
Dr. David Reddy, Director General, IFPMA, and Dr. Bettina Hamelin, President, IMC, jointly advocate for health innovation at the 2025 G7 Summit in Kananaskis (15-17 June). They call G7 leaders to place health and life-sciences innovation at the heart of the G7 agenda, emphasizing three areas of focus where the pharmaceutical industry can drive impact.
Read more
The founding members of the African Medicine Agency Treaty Alliance: Amref Health Africa, the Association of African Universities North Africa Regional Office, the International Alliance of Patients’ Organizations, the International Federation of Pharmaceutical Manufacturers and Associations, the International Pharmaceutical Students’ Federation, NCD Alliance Kenya, PATH, Speak up Africa and the University of the Witwatersrand, welcome...
Read moreOn 4 June 2025, the African Medicines Agency (AMA) announced the appointment of Dr Delese Mimi Darko, Chief Executive of the Food and Drugs Authority in Ghana, as its next Director General. This marks a pivotal moment in making the AMA operational. By strengthening regulatory systems, the AMA will enhance the quality, safety, and efficacy...
Read moreThe policy report From protection to prevention: The power of immunization for people living with non-communicable diseases has been commissioned to The Health Policy Partnership (HPP) by IFPMA.
Read more
Prevention is a necessity government must invest in to secure a stable and prosperous future for everyone.
Read more
On 27 May 2025, IFPMA delievered a statement at the 78th session of the World Health Assembly on antimicrobial resistance.
Read moreOn 26 May 2025, the World Heart Federation delivered a statement on substandard and falsified medicines at the 78th session of the World Health Assembly. The World Heart Federation, supported by the Fight the Fakes Alliance, welcomes the independent evaluation of the Member State Mechanism on Substandard and Falsified Medical Products. Globally, countries waste an...
Read moreOn 26 May 2025, the International Alliance of Patients' Organizations, on behalf of the African Medicines Agency Treaty Alliance (AMATA), delivered a statement on substandard and falsified medical products at the 78th session of the World Health Assembly. As a member of AMATA, IFPMA supported this statement.
Read moreOn 24 May 2025, a resolution on rare diseases was adopted at the 78th session of the World Health Assembly. IFPMA issued a statement in support of the resolution. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), together with its member companies and associations, welcomes the adoption of the World Health Assembly (WHA) Resolution...
Read moreOn 24 May 2025 at the 78th session of the World Health Assembly, the International Council of Nurses (ICN) delivered a statement on behalf of the World Health Professions Alliance (WHPA) on UHC and PHC.
Read more